1. Home
  2. ASRT vs BOWN Comparison

ASRT vs BOWN Comparison

Compare ASRT & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • BOWN
  • Stock Information
  • Founded
  • ASRT 1995
  • BOWN 2023
  • Country
  • ASRT United States
  • BOWN United States
  • Employees
  • ASRT N/A
  • BOWN N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • BOWN
  • Sector
  • ASRT Health Care
  • BOWN
  • Exchange
  • ASRT Nasdaq
  • BOWN Nasdaq
  • Market Cap
  • ASRT 91.3M
  • BOWN 100.3M
  • IPO Year
  • ASRT 1997
  • BOWN 2023
  • Fundamental
  • Price
  • ASRT $0.89
  • BOWN $10.92
  • Analyst Decision
  • ASRT Strong Buy
  • BOWN
  • Analyst Count
  • ASRT 4
  • BOWN 0
  • Target Price
  • ASRT $3.19
  • BOWN N/A
  • AVG Volume (30 Days)
  • ASRT 908.1K
  • BOWN 39.8K
  • Earning Date
  • ASRT 11-11-2024
  • BOWN 01-01-0001
  • Dividend Yield
  • ASRT N/A
  • BOWN N/A
  • EPS Growth
  • ASRT N/A
  • BOWN N/A
  • EPS
  • ASRT N/A
  • BOWN 0.39
  • Revenue
  • ASRT $125,763,000.00
  • BOWN N/A
  • Revenue This Year
  • ASRT N/A
  • BOWN N/A
  • Revenue Next Year
  • ASRT $1.84
  • BOWN N/A
  • P/E Ratio
  • ASRT N/A
  • BOWN $28.26
  • Revenue Growth
  • ASRT N/A
  • BOWN N/A
  • 52 Week Low
  • ASRT $0.73
  • BOWN $10.31
  • 52 Week High
  • ASRT $1.80
  • BOWN $10.98
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 43.20
  • BOWN 53.16
  • Support Level
  • ASRT $0.90
  • BOWN $10.93
  • Resistance Level
  • ASRT $1.04
  • BOWN $10.97
  • Average True Range (ATR)
  • ASRT 0.06
  • BOWN 0.02
  • MACD
  • ASRT -0.00
  • BOWN -0.00
  • Stochastic Oscillator
  • ASRT 14.84
  • BOWN 25.13

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About BOWN Bowen Acquisition Corp

Bowen Acquisition Corp is a blank check company.

Share on Social Networks: